Cargando…
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer
BACKGROUND: Ovarian cancer is a metastatic disease and one of the leading causes of gynaecology malignancy-related deaths in women. Cancer stem cells (CSCs) are key contributors of cancer metastasis and relapse. Integrins are a family of cell surface receptors which allow interactions between cells...
Autores principales: | Samardzija, Chantel, Luwor, Rodney B., Quinn, Michael A., Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939035/ https://www.ncbi.nlm.nih.gov/pubmed/27390927 http://dx.doi.org/10.1186/s12885-016-2458-z |
Ejemplares similares
-
A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer
por: Samardzija, Chantel, et al.
Publicado: (2015) -
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
por: Samardzija, Chantel, et al.
Publicado: (2017) -
Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary
por: Samardzija, Chantel, et al.
Publicado: (2012) -
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer
por: Kadife, Elif, et al.
Publicado: (2019) -
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
por: Chan, Emily, et al.
Publicado: (2018)